Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-25

FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Westminster Pharmaceuticals' supplemental application for sevelamer carbonate, enabling its generic product to be marketed. Sevelamer carbonate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)